Can Hepatitis B Be Cured?
Jun 01, 2022
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
Hepatitis B generally refers to hepatitis B virus (HBV) infection, which may be curable. Hepatitis B is classified into acute and chronic forms. Acute hepatitis B in adults is typically a self-limiting disease; with timely treatment, approximately 90% of cases resolve completely, although some progress to chronic infection. In contrast, the cure rate for chronic hepatitis B is low—clinical cure rates are generally below 10%, and the likelihood of complete (functional) cure is even lower.
Hepatitis B is a common disease with an extremely high incidence rate and is contagious. However, in daily life, some people diagnosed with hepatitis B are told it is difficult to cure. So—can hepatitis B be cured?
Can Hepatitis B Be Cured?
Hepatitis B generally refers to viral hepatitis B infection, which may be curable. Hepatitis B is categorized into acute and chronic forms. In adults, acute hepatitis B is typically a self-limiting disease; with timely treatment, approximately 90% of cases resolve completely. However, a subset of patients progress to chronic infection. By contrast, the cure rate for chronic hepatitis B is significantly lower—clinical cure rates are generally below 10%, and complete eradication of the virus is even rarer. “Clinical cure” usually means resolution of symptoms and normalization of liver function tests, though the hepatitis B virus (HBV) may still persist in the body. “Complete cure,” on the other hand, implies total elimination of HBV.
Patients with acute hepatitis B typically do not require antiviral therapy. However, antiviral treatment may be necessary for those with severe disease or for pregnant individuals. Management primarily focuses on ensuring adequate rest, enhancing nutritional support, reducing hepatic burden, and administering hepatoprotective medications—including agents for jaundice reduction—as prescribed by a physician. Recovery usually takes about 4–6 months, after which most patients no longer carry the hepatitis B virus. Chronic hepatitis B patients, however, should seek systematic, standardized medical care at a hospital as soon as possible.
Clinically, antiviral therapy is the mainstay of treatment. Commonly used drugs include nucleos(t)ide analogues such as entecavir and tenofovir, as well as interferon-based therapies. Immunomodulatory treatments may also be employed adjunctively. While many patients remain lifelong carriers of HBV—and thus retain some degree of infectivity—a minority achieve complete viral clearance. We hope this information has been helpful. Wishing you good health and a joyful life!
